Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis

INTRODUCTION: Notwithstanding their numerous advantages, biological treatments have many limitations when treating patients with psoriasis (PsO) and hepatitis B (HB). Clinicians need to pay careful attention to the issue of hepatitis B virus (HBV) reactivation. METHODS: In accordance with the PRISMA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinyu, Zhang, Ming, Chen, Yu, Liu, Yirong, Yu, Yan, Huang, Xiaojie, Gao, Yanqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941054/
https://www.ncbi.nlm.nih.gov/pubmed/35094295
http://dx.doi.org/10.1007/s13555-022-00682-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941054/
https://www.ncbi.nlm.nih.gov/pubmed/35094295
http://dx.doi.org/10.1007/s13555-022-00682-5

Ejemplares similares